AVTX in the 13F filings
Avalo Therapeutics Inc · CUSIP 05338F306
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 15 May 2026
- latest of these filings; the earliest 12 May 2026
- Managers listing it
- 15
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 0 listed it in both
- Shares listed
- 7,285,420
- combined, among listed positions
- Reported value
- $109m
- combined, at the quarter end
Among the 91 comparable managers: 10 buyers (opened or added shares) and 9 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +3,669,803.
Managers listing AVTX in Q1 2026
15 of 15 holders
Largest increases and reductions, by shares
Increases
- Fidelity (FMR LLC)existing position · 2,879,481 shares now+2,659,181
- Farallon Capital Management LLCnew position · 916,000 shares now+916,000
- Balyasny Asset Management LLCexisting position · 731,586 shares now+292,274
- Point72 Asset Management LPexisting position · 916,142 shares now+288,640
- Millennium Management LLCexisting position · 835,484 shares now+175,505
Reductions
- Marshall Wace LLPexisting position · 129,136 shares now-378,414
- Citadel Advisors LLCexisting position · 193,735 shares now-225,756
- Two Sigma Investments LPexisting position · 64,425 shares now-83,812
- ExodusPoint Capital Management LPexisting position · 17,751 shares now-14,516
- Jane Street Group LLCexisting position · 173,320 shares now-5,535
New positions and exits
New (3)
Exited (4)
- Susquehanna International Group LLPwas $3.8m
- Woodline Partners LPwas $945k
- Walleye Capital LLCwas $757k
- Acadian Asset Management LLCwas $26k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2026 | 1 | $14m | 10 | 9 |
| Q2 2026 | 2 | $90m | 17 | 7 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
AVTX and LLY →AVTX and JNJ →AVTX and VRTX →Choose a stock to compare with AVTX →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own AVTX, latest filings →Back to the 13F Explorer →